Calvin--you really seem to know what you are talking about on assay reports. So you must be pretty ticked off with SLI.v management to somehow release news that makes the stock go down to 60% and, when they try to get it right the second time, the stock still goes down.
I wish I could say I am more encouraged--but the declining price is a referendum of sorts by multiple shareholders/investors and their interpretation of the assay news. And the votes keep on coming in.
And the price keeps on declining.
Calvin--something is amiss. Murray? Laurie? Someone?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.